• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Derm division

Quote




















Actually its everyone that left his dumb ass and every sane person still there that has had interactions with him. 1 person, you are crazy! Good managers don't have nearly their entire team leave because of them! That is when you know you have a major problem and who that problem is you dummy! You seem to be as dumb as he is!
 








Here goes: Below is the breakdown of all the people that have left (I'm sure there are some that are missing). If you are looking to come here, let this be a warning that there are serious management issues. Don't say you weren't warned!

HO:
1. Kym A
2. Bruce H
3. Gary T
4. Matt Z
5. Matt R
6. Dr. Allen K
7. Dr Jim K
8. D. Tay
(and of course Brian & Greg)

8 DM Spots = more than 100% turnover in DM's:
1. Jim M
2. Kathy B
3. Tim C
4. Andrea L
5. Bill C
6. Holly M
7. Patty C
8. Tom D
9. Chris U
10. Pete A

70 Territories = more than 50% Turnover with Reps
1. Joe G
2. Ian W
3. Nicole M
4. Melinda F
5. Sue L
6. Brian Z
7. Victoria C
8. Lisa B
9. Lindsay C
10. Jamie P
11. Doug P
12. Ruby B
13. Jennifer K
14. Dolan S
15. Angela B
16. Ali H
17. Ross M
18. Shannon H
19. Deb A
20. Shanna K
21. Larry K
22. John M
23. Van M
24. Tony L
25. Jeff M
26. Rod M
27. Marc Y
28. Karen T
29. Amy Y
30. Jessica D
31. Lara M
32. Eric C
33. Liz V
34. Brad J
35. John B
36. Brian F
37. Lorin L
38. Eric P
39. Jason Z
40. Amy A
41. David L
42. Emily U
43. The female rep in California that I can't remember
44. ?????????

Remember there are only 70 territories
 








As one of the names on this list, I appreciate whoever is maintaining it. I like knowing my former co-workers are escaping and finding better jobs with futures. Please keep us informed of the next POA and how home office continues the spin of "no, THIS TIME we have the right people."
 
























Anonymous said:
Clearly, yes I am. Not currently in derm, curious if this is a door opener for the specialty or so bad there's no redeeming value at all.
Click to expand...

Take it from a former employee (one of the many on the list above). This division is so poorly run by BG and MF but they have been very lucky with a good product. Put them at any other company and they would have both been run out of town years ago. Some people do well, so some stay. But I guarantee you that if you privately polled the sales force, they would be given an average of 0% confidence in their ability to lead a group of people. They have no direction/vision. They have had basically 1 product for 10+ years and their solution to it going generic in a few years? Switch them to a new formulation (foam). Pathetic. If it was that game changing in the rosacea market, why shelve it for 5 years? Conveniently bring it out at the end of the gels lifecycle and only pay the reps if they get them to switch the rx's. By this time next year they will still only have Fiancee (I don't really consider Desonate a product) but they will be hawking a different version of Fiancee (foam). I'm not suggesting the foam is bad, but when you pay the reps only for the foam and not all the work they have put into the gel over the years, in an environment that will be next to impossible to switch (3-5 years ago no problem - look at what Galderma did switching everyone from .75 to 1%) but this is a different time.

Long story short - the people here are great but like I said scroll through and see the incredible amount of turnover and you will get your answer if things at Bayer Dermatology are "that bad". Yes, yes they are and its all in the leadership (or lack thereof).

And a final note, dermatology is essentially primary care. I don't think it gets you any closer to your ultimate goal of "specialty sales".
 




Anonymous said:
Take it from a former employee (one of the many on the list above). This division is so poorly run by BG and MF but they have been very lucky with a good product. Put them at any other company and they would have both been run out of town years ago. Some people do well, so some stay. But I guarantee you that if you privately polled the sales force, they would be given an average of 0% confidence in their ability to lead a group of people. They have no direction/vision. They have had basically 1 product for 10+ years and their solution to it going generic in a few years? Switch them to a new formulation (foam). Pathetic. If it was that game changing in the rosacea market, why shelve it for 5 years? Conveniently bring it out at the end of the gels lifecycle and only pay the reps if they get them to switch the rx's. By this time next year they will still only have Fiancee (I don't really consider Desonate a product) but they will be hawking a different version of Fiancee (foam). I'm not suggesting the foam is bad, but when you pay the reps only for the foam and not all the work they have put into the gel over the years, in an environment that will be next to impossible to switch (3-5 years ago no problem - look at what Galderma did switching everyone from .75 to 1%) but this is a different time.

Long story short - the people here are great but like I said scroll through and see the incredible amount of turnover and you will get your answer if things at Bayer Dermatology are "that bad". Yes, yes they are and its all in the leadership (or lack thereof).

And a final note, dermatology is essentially primary care. I don't think it gets you any closer to your ultimate goal of "specialty sales".
Click to expand...

Thank you.
 
















Top Bottom
Back
Quote